Current Obesity Reports

, Volume 3, Issue 2, pp 286–290 | Cite as

The BMI: Is It Time to Scratch for a More Accurate Assessment of Metabolic Dysfunction?

Obesity Treatment (CM Apovian, Section Editor)


The body mass index (BMI = Kg/M2) is not a valid measure for clinical decisions, especially whether a patient will benefit from bariatric surgery. The measure, as used, discriminates against the muscular, the aged, women, and racial groups such as Asians and African Americans. The requirement must be eliminated since it denies many patients the only currently available therapy. This chapter provides the bibliographic data to support this argument and should prove useful in convincing carriers that the BMI is an inaccurate and, too often, cruel guideline.


BMI Obesity Bariatric surgery Metabolic syndrome 


Compliance with Ethics Guidelines

Conflict of Interest

E. Charles Moore declares that he has no conflict of interest.

Walter J. Pories has received grant support from Johnson & Johnson, Ethicon, Golden Leaf, GlaxoSmithKline, and National Institutes of Health.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr. 1992;55(2 Suppl):615S–9S.Google Scholar
  2. 2.•
    Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311–21. Interesting evidence of the exploding diabetes epidemic.PubMedCrossRefGoogle Scholar
  3. 3.
    Boudreau DM, Malone DC, Raebel MA, Fishman PA, Nichols GA, Feldstein AC, et al. Health care utilization and costs by metabolic syndrome risk factors. Metab Syndr Relat Disord. 2009;7(4):305–14.PubMedCrossRefGoogle Scholar
  4. 4.••
    Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76. Critical reference. Prospective randomized study of surgical vs. medical therapy for type 2 diabetes.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.••
    Look AHEAD Research Group, Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369(2):145–54. Extensive, very expensive study that documented the failure of diets in the treatment of obesity and its co-morbidities.PubMedCrossRefGoogle Scholar
  6. 6.
    Ikramuddin S, Korner J, Lee WJ, Connett JE, Inabnet WB, Billington CJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA. 2013;309(21):2240–9.PubMedCrossRefGoogle Scholar
  7. 7.
    James PD, Kaplan GG, Myers RP, Hubbard J, Aziz M, Shaheen A, et al. Decreasing mortality from acute biliary diseases requiring endoscopic retrograde cholangiopancreatography: a nationwide cohort study. Clin Gastroenterol Hepatol. 2013;pii: S1542-3565(13):01467–5.Google Scholar
  8. 8.
    Metabolic syndrome. Accessed 10 Oct 2013.
  9. 9.
    Cheung BM, Ong KL, Man YB, Wong LY, Lau CP, Lam KS. Prevalence of the metabolic syndrome in the United States National Health and Nutrition Examination Survey 1999-2002 according to different defining criteria. J Clin Hypertens (Greenwich). 2006;8(8):562–70.CrossRefGoogle Scholar
  10. 10.
    WHO. BMI Classification. Accessed 10 Oct 2013.
  11. 11.
    Lear SA, Toma M, Birmingham CL, Frohlich JJ. Modification of the relationship between simple anthropometric indices and risk factors by ethnic background. Metabolism. 2003;52(10):1295–301.PubMedCrossRefGoogle Scholar
  12. 12.
    Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet. 2000;356(9226):279–84.PubMedCrossRefGoogle Scholar
  13. 13.
    Vassy JL, Shrader P, Yang Q, Liu T, Yesupriya A, Chang MH, et al. Genetic associations with metabolic syndrome and its quantitative traits by race/ethnicity in the United States. Metab Syndr Relat Disord. 2011;9(6):475–82.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Razak F, Anand SS, Shannon H, Vuksan V, Davis B, Jacobs R, et al. Defining obesity cut points in a multiethnic population. Circulation. 2007;115(16):2111–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Brodie D, Moscrip V, Hutcheon R. Body composition measurement: a review of hydrodensitometry, anthropometry, and impedance methods. Nutrition. 1998;14(3):296–310.PubMedCrossRefGoogle Scholar
  16. 16.
  17. 17.
    Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116(1):39–48.PubMedCrossRefGoogle Scholar
  18. 18.
    Cohen RV, Pinheiro JC, Schiavon CA, Salles JE, Wajchenberg BL, Cummings DE. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care. 2012;35(7):1420–8.PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Cohen R, Caravatto PP, Petry T, Cummings D. Role of metabolic surgery in less obese or non-obese subjects with type 2 diabetes: influence over cardiovascular events. Curr Atheroscler Rep. 2013;15(10):355.PubMedCrossRefGoogle Scholar
  20. 20.
    Sjoström K, Anveden A, Peltonen M, Jacobson P, Romeo S, Svensson PA, et al. Evaluation of current eligibility criteria for bariatric surgery: diabetes prevention and risk factor changes in the Swedish obese subjects (SOS) study. Diabetes Care. 2013;36(5):1335–40.PubMedCrossRefGoogle Scholar
  21. 21.
    Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13(3):275–86.PubMedCrossRefGoogle Scholar
  22. 22.
    Chang H, Simonsick E, Ferrucci L, Cooper J. Validation study of the body adiposity index as a predictor of percent body fat in older individuals: Findings from the BLSA. J Gerontol A Biol Sci Med Sci. 2013.Google Scholar
  23. 23.
    Bergman RN, Stefanovski D, Buchanan TA, et al. A better index of body adiposity. Obesity (Silver Spring). 2011;19:1083–9.PubMedCentralCrossRefGoogle Scholar
  24. 24.
    Pories WJ, Dohm LG, Mansfield CJ. Beyond the BMI: the search for better guidelines for bariatric surgery. Obesity (Silver Spring). 2010;18(5):865–71.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of Surgery, Brody School of MedicineEast Carolina UniversityGreenvilleUSA

Personalised recommendations